logo
AI Icon𝛼SK or Search
ENTITY

Symbio Pharmaceuticals (4582 JP)

42
Analysis
Health Care • Japan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
Exchange Announcement • 07 May 2026 14:30

Summary Of Consolidated Financial Statements For The Three Months Ended March 31, 2026 [Japanese Gaap]

Exchange Announcement • 05 Feb 2026 14:30

Summary Of Financial Statements For The Fiscal Year Ended December 31, 2025 [Japanese Gaap] (Consolidated)

Exchange Announcement • 30 Oct 2025 14:30

Summary Of Consolidated Financial Statements For The First Nine Months Of The Fiscal Year Ending December 31, 2025 [Japanese Gaap]

Exchange Announcement • 31 Jul 2025 14:30

Summary Of Consolidated Financial Statements For The First Six Months Of Fiscal Year Ending December 31, 2025 [Japanese Gaap]

Exchange Announcement • 10 Jun 2025 14:30

Revision To Earnings Forecast For Fy 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1

x